Expired Tender Bulgaria ICB TOT Ref. 20528643

Contract notice: Pharmaceutical products Tender - 20528643

Tender notice from Bulgaria, published on 10 Feb 2018.

Executive Summary

The МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ „Д-Р ТОТА ВЕНКОВА” АД has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 10 Feb 2018 and is scheduled to close on 15 Mar 2018, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 20528643, while the tender notice number is 060520-2018 and Register on the platform.

Key facts

Summary
Contract notice: Pharmaceutical products
TOT Ref. No.
20528643
Document Ref. No.
060520-2018
Country
Bulgaria
Notice type
Tender
Competition
ICB
Publication date
10 Feb 2018
Bid deadline
15 Mar 2018
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Pharmaceutical products
Description: Contract notice: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33610000, 33600000, 33610000, 33620000, 33622000, 33631000, 33641000, 33642000, 33651000, 33632000, 33661000, 33691000, 33670000, 33662000
CPV Description: Pharmaceutical products.
Medicinal products for the alimentary tract and metabolism.
Medicinal products for the blood, blood-forming organs and the cardiovascular system.
Medicinal products for the cardiovascular system.
Medicinal products for dermatology.
Medicinal products for the genitourinary system and sex hormones.
Systemic hormonal preparations, excl. sex hormones.
General anti-infectives for systemic use and vaccines.
Medicinal products for the musculo-skeletal system.
Medicinal products for the nervous system.
Antiparasitic products, insecticides and repellents.
Medicinal products for the respiratory system.
Medicinal products for sensory organs.
Доставка на лекарствени продукти (лекарствени продукти, лечебни храни, диагностични средства и други нетерапевтични продукти) за нуждите-of the "Dr. Tota Venkova" Hospital, Gabrovo
Supply of medicinal products (medicinal products, curative foods, diagnostics and other non-therapeutic products) for the needs of "Tota Venkova" Hospital, Gabrovo, divided into 13 positions and the corresponding subheadings detailed in Chapter 2 "Technical Specifications".a and the metabolism A
01.01. Famotidine powd.inj. 20mg solv. 5ml A02BA03 fl. (Amp.) 14 000;
01.02. Famotidine tabl. 20 mg x30 A02BA03 tab. (caps.) 15, 000;
01.03. Omeprazole caps. 20 mg x30 A02BC01 table. (caps.) 1000;
01.04. Omeprazole powd.inj. 40 mg A02BC01, f. (amp.) 3500;
01.05. Lansoprazole caps. 30 mg A02BC03 tab. (caps.) 1000;
01.06. Esomeprazole powd.inj./inf. 40 mg 15 ml A02BC05 f. (amp.)500;
01.07. Papaverine hydrochloride sol.inj. 20 mg/ml 1ml A03AD01 фл. (амп.) 2000;
01.08. Papaverine hydrochloride tabl. 50 mg x40 A03AD01 табл. (капс.) 2000;
01.09. Drotaverine hydrochloride sol.inj. 20 mg/ml 2ml A03AD02 фл. (амп.) 9000;
01.10. Atropine sulfate sol.inj. 1 mg/ml 1 ml A03BA01 фл. (амп.) 1000;
01.11. Hyoscine butylbromide sol. inj. 20 mg/ml 1ml A03BB01 фл. (амп.) 2500;
01.12. Metamizole sodium 500 mg, Pitofenone hydrochloride 5 mg, Fenpiverine hydrochloride 0.1 mg tabl. x20 A03DA02 табл. (капс.) 2000;
01.13. Metamizole sodium 500 mg/ml, Pitofenone hydrochloride 2 mg/ml, Fenpiverine hydrochloride 0.02 mg/ml sol.inj. 2 ml A03DA02 фл. (амп.) 2000;
01.14. Metoclopramide hydrochloride sol.inj. 5 mg/ml 2 ml A03FA01 фл. (амп.) 9000;
01.15. Metoclopramide hydrochloride tabl. 10 mgx40 A03FA01 tabl. (caps) 400;
01.16. Ondansetron sol.inj. 2 mg / ml 4 ml A04AA01 fl. (amp.) 1200;
01.17. L-ornithine-L-aspartate conc.inf. 5 g. 10ml A05BA fl. (amp.) 500;
01.18. Sylimarin caps. 90 mg x 30 A05BA03 tabl. (caps.) 600;
01.19. Oleum Vaseline 800 g A06AA01 op. 10;
01.20. Bisacodyl supp. 10 mg x6 A06AB02 no. supp. 1200;
01.21. Bisacodyl tabl. 5 mg x 30 A06AB02 tabl. (caps.) 300;
01.22. Magnesulphate sulphate pulp. 30 g A06AD04 op. 1 500;
01.23. Nystatin gran.for oromucosal susp. 100 000 IU / ml 50ml A07AA02 op. 70;
01.24. Carbo activatus pulv. 20 g A07BA01 op. 100;
01.25. Carbo activated tabl. x10 A07BA01 Tab. (caps) 1400;
01.26. Diosmectite powd. 3 g x60 A07BC05 pcs. sachet 4200;
01.27. Loperamide hydrochloride caps. 2 mg x10 A07DA03 table (capsule) 1000;
01.28. Mesalazine tabl. 500 mg x 100 A07EC02 Table (Capes.) 600;
01.29. Lyophylized Saccharomyces Boulardii sach. 250 mg x10 A07FA02 br. Sashchet 1500;
01.30. Lipase 10000 IU, Protease 375 IU, Amylase 7500 IU Tablets. X10 A09AA02 Table (capp.) 120;
01.31. Lyapas 25000 IU, Protease 1000 IU, Amylase 18000 IU caps. X20 A09AA02 Table (caps) 120;
01.32. Insulin human, Biosynthetic sol. 100 IU / ml 3 ml A10AB01 fl. (amp.) 500;
01.33. Insulin human (recombinant DNA origin) susp.inj. 100 IU/ml 3ml A10AC01 фл. (амп.) 100;
01.34. Insulin human, Biosynthetic (Isophane insulin crystals) susp.inj. 100 IU/ml 3ml A10AC01 фл. (амп.) 100;
01.35. Insulin human, Biosynthetic (from soluble fraction) 30IU, Insulin human, Biosynthetic (Isophane insulin crystals) 70IU A10AD01 фл. (амп.) 50;
01.36. Metformin hydrochloride tabl. 850 mg x30 A10BA02 табл. (кaps.) 100;
01.37. Metformin hydrochloride tabl. 1000 mg x30 A10BA02 table. (caps.) 500;
01.38. Gliclazide tabl. 30 mg x60 A10BB09 table. (caps.) 1200;
01.39. Glimepiride tabl. 2 mg x30 A10BB12 table. (caps.) 600;
01.40. Acarbose tabl. 100 mg x30 A10BF01 tab. (caps.) 300;
01.41. Calcitriol capsules 0.25 mcg A11CC04 table. (caps.) 18, 000;
01.42. Thiamine sol.inj. 40 mg / ml 2ml A11DA01 Fl. (amp.) 200;
01.43. Cyanobalamin 0.5 mg/ml, Lidocaine hydrochloride 10mg/ml, Pyridoxine hydrochloride 50mg/ml, Thiamine hydrochloride 50mg/ml sol.inj. 2 ml A11DB фл. (амп.) 3000;
01.44. Pyridoxine Hydrochloride 50mg/ml, Thiamine hydrochloride 100 mg/ml sol.inj. 1 ml A11DB фл. (амп.) 1500;
01.45. Ascorbic acid sol.inj. 100 mg/ml 5 ml A11GA01 фл. (амп.) 2500;
01.46. Pyridoxine Hydrochloride sol.inj. 50 mg/ml 2 mlA11HA02 фл. (амп.) 400;
01.47. Calcium gluconicum sol.inj. 8.94 mg/ml 10 ml A12AA03 фл. (амп.) 2500;
01.48. Magnesium aspartate 140 mg, Potassium aspartate 158 mg tabl. x50 A12BA30 табл. (капс.) 25 000;
01.49. Magnesium sulphate sol.inj. 403, 8 mg/10 ml 10 ml A12CC02 фл. (амп.) 1000;
01.50. Magnesium DL-aspartate tabl. 500 mg x30 A12CC05 табл. (капс.) 4000;
01.51. Ademetionine powd.inj. 500 mg solv. A16AA02 fl. (continued) 2600;
Continued in additional information. Participants must be registered as traders under Bulgarian legislation or legislation of a Member State of the European Union or a State party to the Agreement on the European Economic Area and have the right to carry out wholesale trade of medicinal products in accordance with the LMARM. Participants should hold a valid authorization for wholesale and / or import of medicinal products issued by BDA or a regulatory authority of another Member State under the ninth Chapter "Wholesale of medicinal products" of LMPHM. the participant should provide information indicating the manufacturing authorization number, date of issueand the term of validity for wholesale of medicinal products in Part IV "Selection Criteria", Section A of the EEDOP.
2 Participants involved in positions that are drug-containing medicinal products must be registered as traders under the Bulgarian legislation or under the legislation of a Member State of the European Union or of a State party to the Agreement on the European Unioneconomic area and to have the right to carry out wholesale trade in medicinal products containing narcotic substances under Articles II and III of Art. 3 (2) and (3) of the Ordinance on the Classification of Plants and Substances as Narcotic Drugs in Accordance with the Standards of the Public Health Law (where applicable). Participants should hold a valid license issued under Art. 32 of the ACFAthe participant shall provide information indicating the number of a valid license, the date of issue and the term of validity, issued by the Public Health Service Act when it participates in the supply of medicinal products containing narcotic substances from Annexes 2 and 3 of the ACFA, in Part IV "Selection Criteria", section A of EEDOP.
The Contracting Authority does not invoke in the present procedureabout the economic and financial status within the meaning of Art. 61 of the Public Procurement Act. 30, para. 1 of the PPOOP, the contracting authority has provided the opportunity for submission of tenders for one or more of the nomenclatures in the separate item included in the subject of the public procurement. The Contracting Authority pursuant to Art. 10, para. 2 of the PPA does not require that the groupings have a legal form in order toare part of the award of a public contract, but make provision for the establishment of a legal entity where the participant designated as a contractor is a grouping of natural and / or legal persons. The performance guarantee is 3% of (three per cent) of the value of the contract excluding VAT.
The performance guarantee can be deposited by bank transfer or can be presented in the form of bank guaranteesThe performance guarantee is provided in one of the following forms:
1. cash amount; bank guarantee; insurance to cover the performance by covering the contractor's liability
The performance guarantee under items 1 and 2 may be provided on behalf of the contractor on behalf of a third party guarantor
The participant shall itself select the form of the performance guarantee. of payment: deferredbut not less than 60 calendar days after the submission of an invoice
Time limit for performance of the contract:
The term of this contract is 12 (twelve) months from the date of signing the contract.
Internet address (URL): http://mbalgabrovo.com/
Directive: Classical Directive (2014/24/EU)

Documents

Tender Notice
Login to view

Similar tenders

Bulgaria Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Pharmaceutical products was 15 Mar 2018. Bidding is closed.

This tender has been issued by МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ „Д-Р ТОТА ВЕНКОВА” АД in Bulgaria.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33610000 - Medicinal products for the alimentary tract and metabolism, 33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system, 33622000 - Medicinal products for the cardiovascular system, 33631000 - Medicinal products for dermatology, 33641000 - Medicinal products for the genitourinary system and sex hormones, 33642000 - Systemic hormonal preparations, excl. sex hormones, 33651000 - General anti-infectives for systemic use and vaccines, 33632000 - Medicinal products for the musculo-skeletal system, 33661000 - Medicinal products for the nervous system, 33691000 - Antiparasitic products, insecticides and repellents, 33670000 - Medicinal products for the respiratory system, 33662000 - Medicinal products for sensory organs.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 20528643. The purchaser document reference is 060520-2018.

See the Similar Tenders section on this page or browse other tenders from Bulgaria.

This tender falls under Materials and Products in Bulgaria. Suppliers in these sectors can track similar Bulgaria tenders using CPV-based alerts.